VanEck Associates’s BioLineRX BLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-92
| Closed | -$10K | – | 989 |
|
|
2019
Q3 | $10K | Hold |
92
| – | – | ﹤0.01% | 828 |
|
|
2019
Q2 | $20K | Sell |
92
-6
| -6% | -$1.3K | ﹤0.01% | 814 |
|
|
2019
Q1 | $25K | Buy |
98
+2
| +2% | +$510 | ﹤0.01% | 813 |
|
|
2018
Q4 | $25K | Buy |
96
+35
| +57% | +$9.12K | ﹤0.01% | 779 |
|
|
2018
Q3 | $39K | Buy |
61
+3
| +5% | +$1.92K | ﹤0.01% | 767 |
|
|
2018
Q2 | $31K | Buy |
58
+17
| +41% | +$9.09K | ﹤0.01% | 826 |
|
|
2018
Q1 | $21K | Buy |
41
+3
| +8% | +$1.54K | ﹤0.01% | 717 |
|
|
2017
Q4 | $25K | Sell |
38
-27
| -42% | -$17.8K | ﹤0.01% | 709 |
|
|
2017
Q3 | $44K | Buy |
65
+3
| +5% | +$2.03K | ﹤0.01% | 716 |
|
|
2017
Q2 | $31K | Buy |
+62
| New | +$31K | ﹤0.01% | 728 |
|